BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37068312)

  • 41. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition.
    Song C; Duan C
    Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic organization and expression analysis of the murine Fam3c gene.
    Pilipenko VV; Reece A; Choo DI; Greinwald JH
    Gene; 2004 Jun; 335():159-68. PubMed ID: 15194199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.
    Shome R; Ghosh SS
    Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SchA-p85-FAK complex dictates isoform-specific activation of Akt2 and subsequent PCBP1-mediated post-transcriptional regulation of TGFβ-mediated epithelial to mesenchymal transition in human lung cancer cell line A549.
    Xue X; Wang X; Liu Y; Teng G; Wang Y; Zang X; Wang K; Zhang J; Xu Y; Wang J; Pan L
    Tumour Biol; 2014 Aug; 35(8):7853-9. PubMed ID: 24819169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.
    Fernando RI; Castillo MD; Litzinger M; Hamilton DH; Palena C
    Cancer Res; 2011 Aug; 71(15):5296-306. PubMed ID: 21653678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic variants in the FAM3C gene are associated with lipid traits in Chinese children.
    Song Q; Song J; Li C; Wang Y; Qi L; Wang H
    Pediatr Res; 2021 Feb; 89(3):673-678. PubMed ID: 32316026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice.
    Chen Z; Wang J; Yang W; Chen J; Meng Y; Feng B; Chi Y; Geng B; Zhou Y; Cui Q; Yang J
    Oncotarget; 2017 Dec; 8(62):106038-106049. PubMed ID: 29285313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
    Lee GA; Hwang KA; Choi KC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease.
    Yang J; Guan Y
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():105-11. PubMed ID: 23855304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning, expression, and initial characterization of a novel cytokine-like gene family.
    Zhu Y; Xu G; Patel A; McLaughlin MM; Silverman C; Knecht K; Sweitzer S; Li X; McDonnell P; Mirabile R; Zimmerman D; Boyce R; Tierney LA; Hu E; Livi GP; Wolf B; Abdel-Meguid SS; Rose GD; Aurora R; Hensley P; Briggs M; Young PR
    Genomics; 2002 Aug; 80(2):144-50. PubMed ID: 12160727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
    Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
    J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
    Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
    Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.
    Yochum ZA; Cades J; Wang H; Chatterjee S; Simons BW; O'Brien JP; Khetarpal SK; Lemtiri-Chlieh G; Myers KV; Huang EH; Rudin CM; Tran PT; Burns TF
    Oncogene; 2019 Jan; 38(5):656-670. PubMed ID: 30171258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.
    Brown WS; Akhand SS; Wendt MK
    Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.